V. van Heerden

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

H. Goossens, B. Souweine, P. Póvoa, 2022, Critical Care.

The good, the bad and the ugly: pandemic priority decisions and triage

A. Rhodes, B. Guidet, M. Beil, 2020, Journal of Medical Ethics.